Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Oncotarget, 8, 56, S. 96048-96061
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2017
- Event
-
Veröffentlichung
- (who)
-
Impact Journals, LLC
- (when)
-
2017
- Creator
-
Riedl, Jakob Michael
Posch, Florian
Moik, Florian
Bezan, Angelika
Szkandera, Joanna
Smolle, Maria Anna
Kasparek, Anne-Katrin
Pichler, Martin
Stöger, Herbert
Stotz, Michael
Gerger, Armin
- DOI
-
10.18632/oncotarget.21647
- URN
-
urn:nbn:de:bvb:384-opus4-1027374
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Riedl, Jakob Michael
- Posch, Florian
- Moik, Florian
- Bezan, Angelika
- Szkandera, Joanna
- Smolle, Maria Anna
- Kasparek, Anne-Katrin
- Pichler, Martin
- Stöger, Herbert
- Stotz, Michael
- Gerger, Armin
- Universität Augsburg
- Impact Journals, LLC
Time of origin
- 2017
Other Objects (12)
High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer
MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
Best of ASCO 2022: bladder cancer
MicroRNAs: clinical relevance in colorectal cancer
The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
Inflammation, phagocytosis and cancer: another step in the CD47 act
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer
MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
Best of ASCO 2022: bladder cancer
MicroRNAs: clinical relevance in colorectal cancer
The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
Inflammation, phagocytosis and cancer: another step in the CD47 act
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer
MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
Best of ASCO 2022: bladder cancer
MicroRNAs: clinical relevance in colorectal cancer
The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
Inflammation, phagocytosis and cancer: another step in the CD47 act
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?